Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 58118-8020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 58118-8020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A Close-up Of A Labeldescription Automatically Generated (273b79ac 2c62 4407 9cd1 2a2964ef13ba 00)

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 1)

FDA Label Image

Naloxone Chemical Structure (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 2)

FDA Label Image

Mouth (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 3)

FDA Label Image

Bupren/nalox 2/0.5mg Sl Tablet 30 Count Blister Card (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 4)

FDA Label Image

Bupren/nalox 8/2mg Sl Tablet 30 Count Blister Card (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 5)

Bupren/nalox 8/2mg Sl Tablet 30 Count Blister Card (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 5)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.